Free Trial

Inhibikase Therapeutics (IKT) Income Statement & Balance Sheet

Inhibikase Therapeutics logo
$1.91 -0.07 (-3.54%)
(As of 12:30 PM ET)

Inhibikase Therapeutics Income Statement, Balance Sheet and Cash Flow Statement



This page (NYSE:IKT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners